New CRCs bolster research mission
Eric Arts, HBSc’90, PhD, Microbiology and Immunology, and Andrew Pruszynski, PhD, Physiology and Pharmacology, were announced as the School’s newest Canada Research Chairs (CRC). Arts is a Tier 1 CRC in HIV Pathogenesis and Viral Control. As one of the world’s leading HIV researchers, Arts is developing vaccines to prevent new HIV-1 infections and vaccines to cure people already infected and living with HIV. Pruszynski is a Tier 2 CRC in Sensorimotor Neuroscience. He leverages expertise in robotics and neuroscience to understand the basic neural circuitry that underlies healthy and impaired movement including reaching, grasping and object manipulation. This work will lead to better interventions and rehabilitation strategies following injuries and disease that compromise movement.
